Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Light bulbs might help Alzheimer's patients sleep better and control blood sugar

NCT ID NCT03777722

First seen Oct 31, 2025 · Last updated Jun 22, 2026 · Updated 23 times

Summary

This study tested whether a special type of lighting, called a tailored lighting intervention, could help people with mild to moderate Alzheimer's disease and type 2 diabetes sleep better and improve their metabolism. Sixty-one participants living in assisted living or nursing homes were exposed to either the active lighting or a placebo light for 8 weeks. The goal was to see if the light could reset their internal body clocks, leading to better sleep, mood, and blood sugar control.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS TYPE 2 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Icahn School of Medicine

    New York, New York, 10029, United States

  • Icahn School of Medicine at Mount Sinai

    Albany, New York, 12204, United States

  • Rutgers University

    New Brunswick, New Jersey, 08854, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

tailored lighting intervention (special light bulbs/fixtures)

What this could lead to

If it works, this could offer a simple, drug-free way to improve sleep and metabolic health in people with Alzheimer's disease.

What could go wrong

This is a small, early-stage study with only 61 participants. The lighting may not work for everyone, and results may not apply to people with severe vision problems or insulin-dependent diabetes.

Conditions

The condition(s) this trial relates to.

Alzheimer disease type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.